/
Other
Single Ascending Dose
17
Pipeline Programs↗
21
Active Trials↗
96
Companies Involved↗
Single Ascending Dose is an emerging landscape with 17 programs across 96 companies. The most active players are Metro International Biotech, LLC, Beijing Suncadia Pharmaceuticals Co., Ltd, City Therapeutics.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical
No programs
Phase 116
Phase 21
Phase 3
No programs
Approved
No programs
Analysis
Trial Status
243
clinical trials
Completed197 · 81%
Terminated14 · 6%
Recruiting12 · 5%
Not yet recruiting8 · 3%
Unknown status7 · 3%
Withdrawn4 · 2%
Other1 · 0%
Clinical Trials
Trial Activity
243 trials
Page 1 of 17
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)